Carbapenemase-producing Enterobacteriaceae in Sweden 2007-2013: Experiences from seven years of systematic surveillance and mandatory reporting

Drug Resistance Updates

Volumn 20, Issue , 2015, Pages 29-38

  Löfmark, Sonja ^a   Sjöström, Karin ^a   Mäkitalo, Barbro ^a   Edquist, Petra ^a   Tegmark Wisell, Karin ^a   Giske, Christian G ^a,b,c  

^a SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Carbapenem resistance; CPE; KPC; NDM; OXA 48

Indexed keywords

AMIKACIN; CARBAPENEMASE; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; ERTAPENEM; FOSFOMYCIN; GENTAMICIN; IMIPENEM; MECILLINAM; MEROPENEM; NITROFURANTOIN; PIPERACILLIN PLUS TAZOBACTAM; TIGECYCLINE; TOBRAMYCIN; BACTERIAL PROTEIN; BETA LACTAMASE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL TRANSMISSION; BACTERIUM CULTURE; BACTERIUM ISOLATE; BLOODSTREAM INFECTION; CARBAPENEMASE GENE; CARBAPENEMASE PRODUCING ENTEROBACTERIACEAE; CATHETER INFECTION; ESCHERICHIA COLI; GENE; HEALTH CARE SYSTEM; HOSPITALIZATION; KLEBSIELLA PNEUMONIAE; LIFE THREAT; MANDATORY REPORTING; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SCREENING; SWEDEN; TRAVEL; URINARY TRACT INFECTION; WOUND INFECTION; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; ENZYMOLOGY; GENETICS; GENOTYPE; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; PHENOTYPE; PREVALENCE;

BACTERIAL PROTEINS; BETA-LACTAMASES; DRUG RESISTANCE, BACTERIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; GENOTYPE; HUMANS; MANDATORY REPORTING; PHENOTYPE; PREVALENCE; SWEDEN;

EID: 84930762437     PISSN: 13687646     EISSN: 15322084     Source Type: Journal    
DOI: 10.1016/j.drup.2015.05.001     Document Type: Article

References (34)

1. A. Brolund, P.J. Edquist, B. Makitalo, B. Olsson-Liljequist, T. Soderblom, K.T. Wisell, and C.G. Giske Epidemiology of extended-spectrum beta-lactamase-producing Escherichia coli in Sweden, 2007-2011 Clin. Microbiol. Infect. 20 2014 O344 O352
2. R. Canton, M. Akova, Y. Carmeli, C.G. Giske, Y. Glupczynski, M. Gniadkowski, D.M. Livermore, V. Miriagou, T. Naas, G.M. Rossolini, O. Samuelsen, H. Seifert, N. Woodford, and P. Nordmann Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe Clin. Microbiol. Infect. 18 2012 413 431
3. L. Chen, J.R. Mediavilla, A. Endimiani, M.E. Rosenthal, Y. Zhao, R.A. Bonomo, and B.N. Kreiswirth Multiplex real-time PCR assay for detection and classification of Klebsiella pneumoniae carbapenemase gene (blaKPC) variants J. Clin. Microbiol. 49 2011 579 585
4. European Centre for Disease Prevention and Control Antimicrobial Resistance Surveillance in Europe 2013. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net) 2014
5. European Committee on Antimicrobial Susceptibility testing Guideline for the Detection of Resistance Mechanisms and Specific Resistances of Clinical and/or Epidemiological Importance 2013 Available at http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST-files/Resistance-mechanisms/EUCAST-detection-of-resistance-mechanisms-v1.0-20131211.pdf
6. European Committee on Antimicrobial Susceptibility Testing Breakpoint Tables for Interpretation of MICs and Zone Diameters. Version 4.0 2014 http://www.eucast.org
7. S. Fournier, C. Monteil, M. Lepainteur, C. Richard, C. Brun-Buisson, V. Jarlier, and AP-HP Outbreaks Control Group Long-term control of carbapenemase-producing Enterobacteriaceae at the scale of a large French multihospital institution: a nine-year experience, France, 2004 to 2012 Euro Surveill. 19 2014
8. C.G. Giske, A.S. Sundsfjord, G. Kahlmeter, N. Woodford, P. Nordmann, D.L. Paterson, R. Canton, and T.R. Walsh Redefining extended-spectrum beta-lactamases: balancing science and clinical need J. Antimicrob. Chemother. 63 2009 1 4
9. C. Glasner, B. Albiger, G. Buist, A. Tambic Andrasevic, R. Canton, Y. Carmeli, A.W. Friedrich, C.G. Giske, Y. Glupczynski, M. Gniadkowski, D.M. Livermore, P. Nordmann, L. Poirel, G.M. Rossolini, H. Seifert, A. Vatopoulos, T. Walsh, N. Woodford, T. Donker, D.L. Monnet, H. Grundmann, and European Survey on Carbapenemase-Producing Enterobacteriaceae Working Group Carbapenemase-producing Enterobacteriaceae in Europe: a survey among national experts from 39 countries Euro Surveill. 18 February 2013
10. H. Grundmann, D.M. Livermore, C.G. Giske, R. Canton, G.M. Rossolini, J. Campos, A. Vatopoulos, M. Gniadkowski, A. Toth, Y. Pfeifer, V. Jarlier, and Y. Carmeli Carbapenem-non-susceptible Enterobacteriaceae in Europe: conclusions from a meeting of national experts Euro Surveill. 15 2010
11. H. Hanberger, G. Skoog, A. Ternhag, and C.G. Giske Antibiotic consumption and antibiotic stewardship in Swedish hospitals, Upsala J Med. Sci. 119 2014 154 161
12. P.M. Hawkey The growing burden of antimicrobial resistance J. Antimicrob. Chemother. 62 Suppl. 1 2008 i1 i9
13. A.P. Johnson, and N. Woodford Global spread of antibiotic resistance: the example of New Delhi metallo-beta-lactamase (NDM)-mediated carbapenem resistance J. Med. Microbiol. 62 2013 499 513
14. A. Krüttgen, S. Razavi, M. Imöhl, and K. Ritter Real-time PCR assay and a synthetic positive control for the rapid and sensitive detection of the emerging resistance gene New Delhi Metallo-β-lactamase-1 (blaNDM-1) Med. Microbiol. Immunol. 200 2011 137 141
15. Kumarasamy Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study Lancet Infect. Dis. 10 2010 597 602
16. Y.K. Kwak, P. Colque, S. Byfors, C.G. Giske, R. Mollby, and I. Kuhn Surveillance of antimicrobial resistance among Escherichia coli in wastewater in Stockholm during 1 year: does it reflect the resistance trends in the society? Int. J. Antimicrob. Agents 45 2015 25 32
17. D.M. Livermore, M. Warner, S. Mushtaq, M. Doumith, J. Zhang, and N. Woodford What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline Int. J. Antimicrob. Agents 37 2011 415 419
18. A.P. Magiorakos, A. Srinivasan, R.B. Carey, Y. Carmeli, M.E. Falagas, C.G. Giske, S. Harbarth, J.F. Hindler, G. Kahlmeter, B. Olsson-Liljequist, D.L. Paterson, L.B. Rice, J. Stelling, M.J. Struelens, A. Vatopoulos, J.T. Weber, and D.L. Monnet Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance Clin. Microbiol. Infect. 18 2012 268 281
19. R.E. Mendes, K.A. Kiyota, J. Monteiro, M. Castanheira, S.S. Andrade, A.C. Gales, A.C.C. Pignatari, and S. Tufik Rapid detection and identification of metallo-β-lactamase-encoding genes by multiplex real-time PCR assay and melt curve analysis J. Clin. Microbiol. 45 2007 544 547
20. T. Naas, A. Ergani, A. Carrër, and P. Nordmann Real-time PCR for detection of NDM-1 carbapenemase genes from spiked stool samples Antimicrob. Agents Chemother. 55 2011 4038 4043
21. H. Nilholm, L. Holmstrand, J. Ahl, F. Månsson, I. Odenholt, J. Tham, E. Melander, and F. Resman An audit-based, infectious disease specialist-guided antimicrobial stewardship program profoundly reduced antibiotic use without negatively affecting patient outcomes Open Forum Infect. Dis. 2 spring (2) 2015
22. P. Nordmann, T. Naas, and L. Poirel Global spread of carbapenemase-producing Enterobacteriaceae Emerg. Infect. Dis. 17 2011 1791 1798
23. P. Nordmann, L. Poirel, T.R. Walsh, and D.M. Livermore The emerging NDM carbapenemases Trends Microbiol. 19 2011 588 595
24. S. Ny, S. Löfmark, S. Börjesson, S. Englund, M. Ringman, J. Bergström, P. Naucler, C. Giske, and S. Byfors Circulation of ESBL-producing E. coli in the Swedish population; a comparison of isolates from community carriers, non-invasive- and invasive infections ECCMID-3172 (Abstract) 2015
25. M. Osterblad, J. Kirveskari, A.J. Hakanen, P. Tissari, M. Vaara, and J. Jalava Carbapenemase-producing Enterobacteriaceae in Finland: the first years (2008-11) J. Antimicrob. Chemother. 67 2012 2860 2864
26. J. Oteo, D. Saez, V. Bautista, S. Fernandez-Romero, J.M. Hernandez-Molina, M. Perez-Vazquez, B. Aracil, J. Campos, and Spanish Collaborating Group for the Antibiotic Resistance Surveillance Program Carbapenemase-producing enterobacteriaceae in Spain in 2012 Antimicrob. Agents Chemother. 57 2013 6344 6347
27. G. Patel, and R.A. Bonomo Stormy waters ahead: global emergence of carbapenemases Front. Microbiol. 4 2013 48
28. L. Poirel, T.R. Walsh, V. Cuvillier, and P. Nordmann Multiplex PCR for detection of acquired carbapenemase genes Diagn. Microbiol. Infect. Dis. 70 2011 119 123
29. J.M. Rolain, and G.G. Cornaglia Carbapenemases in Enterobacteriaceae: the magnitude of a worldwide concern Clin. Microbiol. Infect. 20 9 2014 819 820
30. P. Rolfhamre, A. Jansson, M. Arneborn, and K. Ekdahl SmiNet-2: description of an internet-based surveillance system for communicable diseases in Sweden Euro Surveill. 11 2006 103 107
31. ∅. Samuelsen, C.M. Thilesen, L. Heggelund, A.N. Vada, A. Kummel, and A. Sundsfjord Identification of NDM-1-producing Enterobacteriaceae in Norway J. Antimicrob. Chemother. 66 2011 670 672
32. T. Tangden, and C.G. Giske Global dissemination of extensively drug-resistant carbapenemase-producing Enterobacteriaceae: clinical perspectives on detection, treatment and infection control J. Intern. Med. 277 5 2015 501 512
33. N. Woodford, J.F. Turton, and D.M. Livermore Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance FEMS Microbiol. Rev. 35 2011 736 755
34. J.J. Yan, P.R. Hsueh, W.C. Ko, K.T. Luh, S.H. Tsai, H.M. Wu, and J.J. Wu Metallo-beta-lactamases in clinical Pseudomonas isolates in Taiwan and identification of VIM-3, a novel variant of the VIM-2 enzyme Antimicrob. Agents Chemother. 45 2001 2224 2228